Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
CA 2175467 A1 · Owner: Mitchell, James B. · Inventors: Granger, Daniel Neil; Wink, David A. Jr.; Grisham, Matthew B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for treating oxygen free radical induced tissue damage associated with ischemia reperfusion injury, wherein nitric oxide is delivered to target cells/tissues through the administration of a nitric-oxide-containing compound that spontaneously releases nitric oxide under physiological conditions without requiring the presence of oxygen.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 31, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.